Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1977 Aug;17(2):350–355. doi: 10.1128/iai.17.2.350-355.1977

In vitro studies on the mechanism of herpesvirus plaque growth inhibition by sensitized lymphocytes.

Y M Centifanto, Z S Zam, H E Kaufman
PMCID: PMC421126  PMID: 197019

Abstract

Inhibition of herpesvirus plaque growth was observed when herpes simplex virus (HSV)-sensitized rabbit lymphocytes were placed in contact with an HSV-infected human foreskin monolayer. This inhibition was obtained as early as 3 h when a ratio of 6 viable lymphocytes to target cells was used, and the supernatants of these cultures also demonstrated plaque size reduction when put onto newly infected cell monolayers. Interferon, which is present in this system, had no effect on HSV when tested on human foreskin monolayers, indicating that interferon was not the mechanism for plaque size reduction. Plaque growth inhibition was attributed to the T lymphocyte, because purified T cells reduced plaque growth and anti-rabbit thymocyte serum eliminated the effect of T cells. The specificity of this assay was determined by the facts that nonsensitized lymphocytes did not reduce the size of a plaque and the recognition of an infected cell by the sensitized lymphocyte was necessary for the release of a soluble mediator into the supernatant fluid. This cytotoxic lymphocyte was detected in the peripheral blood of rabbits as early as 4 days after initial corneal infection, with a maximum response at 7 to 10 days.

Full text

PDF
350

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ennis F. A. Host defense mechanisms against Herpes simplex virus. I. Control of infection in vitro by senstized spleen cells and antibody. Infect Immun. 1973 Jun;7(6):898–904. doi: 10.1128/iai.7.6.898-904.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Ennis F. A. Host defense mechanisms against herpes simplex virus. II. Protection conferred by sensitized spleen cells. J Infect Dis. 1973 Jun;127(6):632–638. doi: 10.1093/infdis/127.6.632. [DOI] [PubMed] [Google Scholar]
  3. Julius M. H., Simpson E., Herzenberg L. A. A rapid method for the isolation of functional thymus-derived murine lymphocytes. Eur J Immunol. 1973 Oct;3(10):645–649. doi: 10.1002/eji.1830031011. [DOI] [PubMed] [Google Scholar]
  4. Kaufman H. E., Brown D. C., Ellison E. D. Herpes virus in the lacrimal gland, conjunctiva and cornea of man--a chronic infection. Am J Ophthalmol. 1968 Jan;65(1):32–35. doi: 10.1016/0002-9394(68)91024-6. [DOI] [PubMed] [Google Scholar]
  5. Kaufman H. E., Brown D. C., Ellison E. M. Recurrent herpes in the rabbit and man. Science. 1967 Jun 23;156(3782):1628–1629. doi: 10.1126/science.156.3782.1628. [DOI] [PubMed] [Google Scholar]
  6. Little J. M., Centifanto Y. M., Kaufman H. E. Immunoglobulins in human tears. Am J Ophthalmol. 1969 Nov;68(5):898–905. doi: 10.1016/0002-9394(69)94587-5. [DOI] [PubMed] [Google Scholar]
  7. Lodmell D. L., Niwa A., Hayashi K., Notkins A. L. Prevention of cell-to-cell spread of herpes simplex virus by leukocytes. J Exp Med. 1973 Mar 1;137(3):706–720. doi: 10.1084/jem.137.3.706. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Lodmell D. L., Notkins A. L. Cellular immunity to herpes simplex virus mediated by interferon. J Exp Med. 1974 Sep 1;140(3):764–778. doi: 10.1084/jem.140.3.764. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Oakes J. E. Role for cell-mediated immunity in the resistance of mice to subcutaneous herpes simplex virus infection. Infect Immun. 1975 Jul;12(1):166–172. doi: 10.1128/iai.12.1.166-172.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Rasmussen L. E., Jordan G. W., Stevens D. A., Merigan T. C. Lymphocyte interferon production and transformation after Herpes simplex infections in humans. J Immunol. 1974 Feb;112(2):728–736. [PubMed] [Google Scholar]
  11. Rosenberg G. L., Farber P. A., Notkins A. L. In vitro stimulation of sensitized lymphocytes by herpes simplex virus and vaccinia virus. Proc Natl Acad Sci U S A. 1972 Mar;69(3):756–760. doi: 10.1073/pnas.69.3.756. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Russell A. S. Cell-mediated immunity to herpes simplex virus in man. J Infect Dis. 1974 Feb;129(2):142–146. doi: 10.1093/infdis/129.2.142. [DOI] [PubMed] [Google Scholar]
  13. Russell A. S., Kaiser J., Lao V. S. Cell mediated immunity to herpes simplex in man. IV. A correlation of lymphocyte stimulation and inhibition of leukocyte migration. J Immunol Methods. 1976;9(3-4):273–279. doi: 10.1016/0022-1759(76)90202-7. [DOI] [PubMed] [Google Scholar]
  14. Russell A. S., Percy J. S., Kovithavongs T. Cell-mediated immunity to Herpes simplex in humans: lymphocyte cytotoxicity measured by 51-Cr release from infected cells. Infect Immun. 1975 Feb;11(2):355–359. doi: 10.1128/iai.11.2.355-359.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Shore S. L., Black C. M., Melewicz F. M., Wood P. A., Nahmias A. J. Antibody-dependent cell-mediated cytotoxicity to target cells infected with type 1 and type 2 herpes simplex virus. J Immunol. 1976 Jan;116(1):194–201. [PubMed] [Google Scholar]
  16. Shore S. L., Cromeans T. L., Romano T. J. Immune destruction of virus-infected cells early in the infectious cycle. Nature. 1976 Aug 19;262(5570):695–696. doi: 10.1038/262695a0. [DOI] [PubMed] [Google Scholar]
  17. Simmons R. L., Centifanto Y., Kaufman H. E. Plaque size reduction as a measure of viral cell-mediated immunity. Infect Immun. 1974 Nov;10(5):1034–1039. doi: 10.1128/iai.10.5.1034-1039.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Stevens J. G., Nesburn A. B., Cook M. L. Latent herpes simplex virus from trigeminal ganglia of rabbits with recurrent eye infection. Nat New Biol. 1972 Feb 16;235(59):216–217. doi: 10.1038/newbio235216a0. [DOI] [PubMed] [Google Scholar]
  19. Thong Y. H., Vincent M. M., Hensen S. A., Fuccillo D. A., Rola-Pleszczynski M., Bellanti J. A. Depressed specific cell-mediated immunity to Herpes simplex virus type 1 in patients with recurrent herpes labialis. Infect Immun. 1975 Jul;12(1):76–80. doi: 10.1128/iai.12.1.76-80.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Wilton J. M., Ivanyi L., Lehner T. Cell-mediated immunity in Herpesvirus hominis infections. Br Med J. 1972 Mar 18;1(5802):723–726. doi: 10.1136/bmj.1.5802.723. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES